| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/25/2001 | CA2378930A1 Electron transfer proteins |
| 01/25/2001 | CA2378917A1 Melanin-concentrating hormone receptor |
| 01/25/2001 | CA2378249A1 Use of fviia or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis |
| 01/25/2001 | CA2378061A1 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 01/25/2001 | CA2378026A1 Novel glycosyl sulfotransferases gst-4.alpha., gst-4.beta., and gst-6 |
| 01/25/2001 | CA2377906A1 Methods for producing and preparing cells for cell therapy |
| 01/25/2001 | CA2376641A1 Chimeric polypeptides of serum albumin and uses related thereto |
| 01/25/2001 | CA2375458A1 Compositions and methods for the treatment of immune related diseases |
| 01/25/2001 | CA2373690A1 Recombinase-based methods for producing expression vectors and compositions for use in practicing the same |
| 01/25/2001 | CA2371163A1 A method for identifying pre-neoplastic and/or neoplastic states in mammals |
| 01/24/2001 | EP1070757A1 Methods for isolating osteoclast precursor cells and inducing the differentiation of the same into osteoclasts |
| 01/24/2001 | EP1070454A1 Transgenic animal showing vascular tissue-specific expression of angiotensin ii2 receptor |
| 01/24/2001 | EP1070254A1 Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions |
| 01/24/2001 | EP1070143A2 Glaucoma therapeutics and diagnostics |
| 01/24/2001 | EP1070141A1 Immediate early genes and methods of use therefor |
| 01/24/2001 | EP1070134A2 Growth differentiation factor-9 regulatory sequences and uses therefor |
| 01/24/2001 | EP1070133A2 Biological material with increased expression of endogenous complement regulatory molecules |
| 01/24/2001 | EP1070129A2 Dadd, death activator death domain protein |
| 01/24/2001 | EP1070128A1 Axor4 g-protein-coupled receptor |
| 01/24/2001 | EP1070125A2 Human nucleic acid sequences from normal breast tissue |
| 01/24/2001 | EP1070123A2 Herpes simplex virus latency associated transcript polypeptides |
| 01/24/2001 | EP1070120A1 Amp deaminase |
| 01/24/2001 | EP1070081A1 Novel molecules of the t129-related protein family and uses thereof |
| 01/24/2001 | EP1070080A1 HUMAN EDG-1c POLYNUCLEOTIDES AND POLYPEPTIDES AND METHODS OF USE |
| 01/24/2001 | EP1069908A2 Methods and modified cells for the treatment of cancer |
| 01/24/2001 | EP1069822A1 Creation of three-dimensional tissues |
| 01/24/2001 | EP1069821A1 Method of controlling proliferation and differentiation of stem and progenitor cells |
| 01/24/2001 | EP1011518A4 Biological tissue transplant coated with stabilized multilayer alginate coating suitable for transplantation and method for preparation thereof |
| 01/24/2001 | EP0904392B1 Retroviral vectors |
| 01/24/2001 | EP0837852B1 Pesticidal sulfur compounds |
| 01/24/2001 | CN1281508A Human Sel-10 polypeptides and polynucleotides that encode them |
| 01/24/2001 | CN1281371A Method for obtaining vaccines for preventing pathogenic effects related to retroviral infection |
| 01/24/2001 | CN1061098C Anti-microbial agents and screening method |
| 01/23/2001 | US6177616 Genes coding for amino acid deacetylases with specificity for N-acetyl-L-phosphinothricin, their isolation and their use |
| 01/23/2001 | US6177556 Nucleotide sequences coding stem cell factor protein; for use in in vitro fertilization therapy |
| 01/23/2001 | US6177549 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof |
| 01/23/2001 | US6177401 Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis |
| 01/23/2001 | US6177270 Reaction-based selection for expression of and concentration of catalytic moieties |
| 01/23/2001 | US6177248 Detecting expression of at least one gene down-stream from wt1 and comparing to wild type cells; a difference suggests mutation; diagnosis of cancer/tumor |
| 01/23/2001 | US6177245 Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms |
| 01/23/2001 | US6177242 Genomic DNA fragments containing regulatory and coding sequences for the β2-subunit of the neuronal nicotinic acetylcholine receptor and transgenic animals made using these fragments or mutated fragments |
| 01/23/2001 | US6177106 Method for fractionating red blood cells and antibacterial materials for bacterial proliferation inhibitors produced thereby |
| 01/18/2001 | WO2001004354A2 Use of ras inhibitors of inhibiting muscle atrophy |
| 01/18/2001 | WO2001004350A1 Cell line comprising the promoter of cyclooxygenase-2 (cox-2) and a witness gene, and use thereof in the search of cox-2 transcriptional induction selective inhibitors |
| 01/18/2001 | WO2001004334A2 Infection with chimaeric adenoviruses of cells negative for the adenovirus serotype 5 coxsacki adenovirus receptor (car) |
| 01/18/2001 | WO2001004333A1 In vitro reconstitution of segmented negative-strand rna viruses |
| 01/18/2001 | WO2001004327A1 Expression of herbicide tolerance genes in plant plastids |
| 01/18/2001 | WO2001004326A1 Tankyrase homolog protein (thp), nucleic acids, and methods related to the same |
| 01/18/2001 | WO2001004318A2 Myxoma virus genes for immune modulation |
| 01/18/2001 | WO2001004313A1 Methods and compositions for preventing the formation of aberrant rna during transcription of a plasmid sequence |
| 01/18/2001 | WO2001004308A1 Human lim domain proteins |
| 01/18/2001 | WO2001004306A1 Expression vectors and methods |
| 01/18/2001 | WO2001004305A2 Human proteins involved in detoxification |
| 01/18/2001 | WO2001004304A1 Human cytokine receptor |
| 01/18/2001 | WO2001004302A1 Atopy gene |
| 01/18/2001 | WO2001004297A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 01/18/2001 | WO2001004294A1 Antimicrobial peptides derived from molluscs |
| 01/18/2001 | WO2001004292A1 G-protein coupled receptor and dna sequences thereof |
| 01/18/2001 | WO2001004282A2 Replication-competent anti-cancer vectors |
| 01/18/2001 | WO2001004281A2 Dna coding for beta-tubulin and use thereof |
| 01/18/2001 | WO2001004269A1 Ligands for use in therapeutic compositions for the treatment of hemostasis disorders |
| 01/18/2001 | WO2001004268A1 Mesenchymal precursor cell |
| 01/18/2001 | WO2001004264A2 Atherosclerosis-associated genes |
| 01/18/2001 | WO2001004148A2 Donor strand complemented pilin and adhesin broad-based vaccines |
| 01/18/2001 | WO2001004144A2 Fabrication of beta-pleated sheet proteins with specific binding properties |
| 01/18/2001 | WO2001004143A2 Prostase vaccine |
| 01/18/2001 | WO2001004141A2 Seripancrin |
| 01/18/2001 | WO2001004140A1 Compounds for treatment of infectious and immune system disorders and methods for their use |
| 01/18/2001 | WO2001004133A1 Human eag2 |
| 01/18/2001 | WO2001003743A1 Manipulation of tissue or organ type using the notch pathway |
| 01/18/2001 | WO2001003737A1 Immunoglobulin fusion proteins |
| 01/18/2001 | WO2001003733A1 Gamma-herpesvirus dna and methods of use |
| 01/18/2001 | WO2001003726A1 Stable factor viii compositions |
| 01/18/2001 | WO2001003709A1 Calcium-containing structures and methods of making and using the same |
| 01/18/2001 | WO2000071670A3 Method for enhancing cellulose and modifying lignin biosynthesis in plants |
| 01/18/2001 | WO2000068383A3 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir) |
| 01/18/2001 | WO2000066755A3 Pesticidal fusions |
| 01/18/2001 | WO2000063415A8 Dna encoding the human vanilloid receptor vr1 |
| 01/18/2001 | WO2000063378A3 Zalpha13: a human secreted protein |
| 01/18/2001 | WO2000060050A3 Recombinant influenza viruses for vaccines and gene therapy |
| 01/18/2001 | WO2000058488A3 Delivery of functional protein sequences by translocating polypeptides |
| 01/18/2001 | WO2000056864A3 Methods for altering substrate specificity of phosphoinositide-dependent-protein kinase 1 (pdk1) |
| 01/18/2001 | WO2000056860A3 Diagnosis and therapy of bone conditions |
| 01/18/2001 | WO2000055180A3 Human lung cancer associated gene sequences and polypeptides |
| 01/18/2001 | WO2000047723A3 Human diacylglycerol kinase beta (hdagk beta) proteins and nucleotide sequences encoding the same |
| 01/18/2001 | WO2000039304A3 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/18/2001 | WO2000023565B1 Novel neuropilin/growth factor binding and uses thereof |
| 01/18/2001 | WO2000018889A3 Sequenzes of putative plant acyltransferases |
| 01/18/2001 | WO2000002911A3 INTERACTION OF HUMAN BETA AMYLOID PRECURSOR PROTEIN (β-APP) WITH HUMAN LON-PROTEASE LIKE PROTEIN (HSLON) |
| 01/18/2001 | WO1999050403A3 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses |
| 01/18/2001 | DE19933288A1 Strukturprotein von Adeno-assoziiertem Virus mit veränderter Antigenität, seine Herstellung und Verwendung Structural protein of adeno-associated virus with altered antigenicity, its preparation and use |
| 01/18/2001 | DE19933089A1 Mittel zur Gewerbsregeneration Means for commercial regeneration |
| 01/18/2001 | DE19933018A1 Flooding apparatus for dental samples has a controlled flooding channels to give a consistent laminar flow over their surfaces for the cultivation of bacterial lesions at dentine in vitro |
| 01/18/2001 | DE19932720A1 Measuring the effect of a substance onto a cell system, comprises immersing the neural cell system into solution and measuring the bioelectric activity of the neurones |
| 01/18/2001 | DE19932688A1 Design von Beta-Faltblatt-Proteinen mit spezifischen Bindungseigenschaften Design of beta-sheet proteins with specific binding properties |
| 01/18/2001 | CA2385102A1 Expression vectors and methods |
| 01/18/2001 | CA2383496A1 Compounds for treatment of infectious and immune system disorders and methods for their use |
| 01/18/2001 | CA2381125A1 Ligands for use in therapeutic compositions for the treatment of hemostasis disorders |
| 01/18/2001 | CA2379133A1 Human proteins involved in detoxification |
| 01/18/2001 | CA2379012A1 In vitro reconstitution of segmented negative-strand rna viruses |